United States · FDA National Drug Code directory
Azelastine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 47335-779_09652cb1-7315-4188-9f36-4e2b50fb764d
- Product NDC
- 47335-779
- Form
- SPRAY, METERED
- Composition / generic term
- Azelastine Hydrochloride
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20120524
- Source listing expiry
- 20261231
Source-listed ingredients
- AZELASTINE HYDROCHLORIDE — 137 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, SPRAY in 1 BOX (47335-779-91) / 200 SPRAY, METERED in 1 BOTTLE, SPRAY · 47335-779-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →